期刊文献+

血清HCY、sd-LDL及脂蛋白相关磷酯酶A2检测在缺血性脑卒中的临床应用价值分析

Analysis of the Clinical Application Value of Serum HCY,sd-LDL and Lipoprotein-associated Phosphatase A2 in Ischemic Stroke
下载PDF
导出
摘要 目的分析血清HCY、sd-LDL及脂蛋白相关磷酯酶A2联合检测对诊断缺血性脑卒中患者的临床价值。方法选取2020年1月—2021年1月在该院住院治疗的缺血性脑卒中患者约200例作为实验组,并选择同期进入该院体检的200名健康人群作为对照组,并对两组患者进行检测,最终评估两组患者血清HCY、sd-LDL及脂蛋白相关磷酯酶A2联合检测的诊断情况。结果实验组患者的血清HCY为(16.54±1.24)μmol/L、sd-LDL为(110.64±21.64)mg/dl、脂蛋白相关磷酯酶A2为(198.67±6.45)μg/L;对照组患者的血清HCY为(12.34±1.35)μmol/L、sd-LDL为(91.24±14.34)mg/dl、脂蛋白相关磷酯酶A2为(96.65±7.54)μg/L,实验组数值均高于对照组,差异有统计学意义(t=32.403、10.568、145.406,P<0.05)。结论对缺血性脑卒中患者检测血清HCY、sd-LDL及脂蛋白相关磷酯酶A2,可以帮助医生更好地诊断患者的实际情况,且缺血性脑卒中患者的各项指标均显著高于正常数值,其具有较高的临床使用价值。 Objective Analyzed the clinical value of combined detection of serum HCY,sd-LDL and lipoprotein-related phosphatase A2 in the diagnosis of ischemic stroke patients.Methods About 200 patients with ischemic stroke who were hospitalized in the hospital from January 2020 to January 2021 were selected as the experimental group,and 200 healthy people who entered the hospital for physical examination during the same period were selected as the control group.The patients were tested,and the diagnosis of the combined detection of serum HCY,sd-LDL and lipoprotein-related phosphatase A2 in the two groups was finally evaluated.Results The serum HCY of the experimental group was(16.54±1.24)μmol/L,the sd-LDL was(110.64±21.64)mg/dl,the lipoprotein-related phosphatase A2 was(198.67±6.45)μg/L;the control group’s serum HCY was(12.34±1.35)μmol/L,sd-LDL was(91.24±14.34)mg/dl,lipoprotein-associated phosphatase A2 was(96.65±7.54)μg/L,the values of the experimental group were higher than those of the control group,the difference was statistically significant(t=32.403,10.568,145.406,P<0.05).Conclusion The detection of serum HCY,sd-LDL and lipoprotein-related phosphatase A2 in patients with ischemic stroke can help doctors better diagnose the actual conditions of patients,and the indicators of patients with ischemic stroke are significantly higher.It has higher clinical value than normal value.
作者 李对红 LI Duihong(Department of Laboratory Medicine,Tianshui Hospital of Traditional Chinese Medicine,Tianshui,Gansu Province,741000 China)
出处 《世界复合医学》 2021年第4期47-49,65,共4页 World Journal of Complex Medicine
基金 血清HCY、sd-LDL及脂蛋白相关磷酯酶A2检测在缺血性脑卒中的临床应用价值分析(2020-SHFZKJK-2846)。
关键词 血清HCY sd-LDL 脂蛋白相关磷酯酶A2 缺血性脑卒中 检测 Serum HCY sd-LDL Lipoprotein-associated phosphatase A2 Ischemic stroke Detection
  • 相关文献

参考文献12

二级参考文献88

  • 1丁宏岩,董强.基底动脉梗死的治疗:动脉和静脉溶栓效果比较的系统分析[J].中国卒中杂志,2006,1(6):414-416. 被引量:126
  • 2蒋兴亮,周京国,唐中,张均.冠心病患者对氧磷酯酶1活性与氧化型低密度脂蛋白的关系[J].中华老年心脑血管病杂志,2004,6(5):305-307. 被引量:8
  • 3钱加强,张志坚,张萍,林健康,李秋兰,吴宝花.对氧磷脂酶-1与氧化低密度脂蛋白在脑梗死发病机制中的作用[J].中国现代神经疾病杂志,2006,6(4):275-278. 被引量:3
  • 4各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33004
  • 5Mackness B,M ackness M. Anti-infiammatory properties ofparaoxonase-1 inatheroselerosis[J]. Adv Ejqj Med Biol,2010,660:143-151.
  • 6Steinberg D. Atherogenesis in perspective: hypercholesterolemiaand inflammation as partners in crime [ J ]. Nat Med,2002,8(11):1211 -1217.
  • 7Sanghera DK,Saha SY,Aston CE,et al. Genetic polymorphism ofparaoxonase and the risk of coronary heart disease [ J ].Arterioscler Thromb Vase Biol, 1997 ,17(6) :1067 - 1073.
  • 8Topenoglu A, Uzun H, Aydin S, et al. The effect of hormone replacement therapy on oxidized low density lipoprotein levels and paraoxonase activity in postmenopausal women[ J]. Tohoku J Exp Med,2005,205( 1 ) :79 -86.
  • 9Gran慼r M, James RW,Kahri J,et al. Association of paraoxonase-1activity and concentration with angiographic severity and extent ofcoronary artery disease [ J ]. J Am Coll Cardiol,2006,47 ( 12):2429 -2435.
  • 10Adnan BA, Ahmet C, Turkay 0, et al. Therelationship betweenparaoxonase enzyme activity and coronary artery disease inpatients with metabolic syndrome [ J ]. Arch Turk Soc Cardiol,2011,39(5) :371 -377.

共引文献99

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部